Connection
Shankar Munusamy to Diabetic Nephropathies
This is a "connection" page, showing publications Shankar Munusamy has written about Diabetic Nephropathies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.449 |
|
|
|
-
Bayne S, LeFevre J, Olstinske K, Ravindran S, Munusamy S. Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease. Adv Biol (Weinh). 2024 03; 8(3):e2300496.
Score: 0.643
-
Ravindran S, Munusamy S. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. J Cell Physiol. 2022 02; 237(2):1182-1205.
Score: 0.556
-
El Gamal H, Eid AH, Munusamy S. Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury. Biomed Res Int. 2017; 2017:5903105.
Score: 0.403
-
ElGamal H, Munusamy S. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges. Protein Pept Lett. 2017; 24(1):71-77.
Score: 0.398
-
Ravindran S, Kuruvilla V, Wilbur K, Munusamy S. Nephroprotective Effects of Metformin in Diabetic Nephropathy. J Cell Physiol. 2017 Apr; 232(4):731-742.
Score: 0.391
-
Munusamy S, MacMillan-Crow LA. Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free Radic Biol Med. 2009 Apr 15; 46(8):1149-57.
Score: 0.058